Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor V Vintonyak

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Organic Letters|February 28, 2008
Formal total synthesis of neopeltolideViktor V Vintonyak, Martin E Maier
Organic Letters|January 30, 2007
Synthesis of the core structure of cruentaren AViktor V Vintonyak, Martin E Maier
Angewandte Chemie (International Ed. in English)|May 25, 2007
Total synthesis of cruentaren AViktor V Vintonyak, Martin E Maier
Bioorganic & Medicinal Chemistry|March 23, 2011
Using small molecules to target protein phosphatasesViktor V Vintonyak, Herbert Waldmann, Daniel Rauh
Current Opinion in Chemical Biology|May 5, 2009
The therapeutic potential of phosphatase inhibitorsViktor V Vintonyak, Andrey P Antonchick, Daniel Rauh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 4, 2008
Total synthesis and biological activity of neopeltolide and analoguesViktor V Vintonyak, Brigitte Kunze, Florenz Sasse, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 29, 2008
Synthesis and biological evaluation of cruentaren A analoguesViktor V Vintonyak, Marcellino Calà, Frank Lay, et al.
Angewandte Chemie (International Ed. in English)|July 16, 2010
Identification of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase BViktor V Vintonyak, Karin Warburg, Holger Kruse, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Organic Letters|February 28, 2008
Formal total synthesis of neopeltolideViktor V Vintonyak, Martin E Maier
Organic Letters|January 30, 2007
Synthesis of the core structure of cruentaren AViktor V Vintonyak, Martin E Maier
Angewandte Chemie (International Ed. in English)|May 25, 2007
Total synthesis of cruentaren AViktor V Vintonyak, Martin E Maier
Bioorganic & Medicinal Chemistry|March 23, 2011
Using small molecules to target protein phosphatasesViktor V Vintonyak, Herbert Waldmann, Daniel Rauh
Current Opinion in Chemical Biology|May 5, 2009
The therapeutic potential of phosphatase inhibitorsViktor V Vintonyak, Andrey P Antonchick, Daniel Rauh, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 4, 2008
Total synthesis and biological activity of neopeltolide and analoguesViktor V Vintonyak, Brigitte Kunze, Florenz Sasse, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 29, 2008
Synthesis and biological evaluation of cruentaren A analoguesViktor V Vintonyak, Marcellino Calà, Frank Lay, et al.
Angewandte Chemie (International Ed. in English)|July 16, 2010
Identification of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase BViktor V Vintonyak, Karin Warburg, Holger Kruse, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Pageof 1